ERBB receptors and cancer: the complexity of targeted inhibitors.
作者： Nancy E. Hynes , Heidi A. Lane
DOI: 10.1038/NRC1609
关键词:
摘要: … In particular, the expression or activation of epidermal … targets, and many ERBB inhibitors are now used in the clinic. We will discuss the significance of these receptors as clinical targets, …
nature.com
sci-hub.se 参考文章(176)
Peter McIntyre, Ruth Jepson, Stephen Leeder, Les Irwig, The outcome of childhood Haemophilus influenzae meningitis. A population based study. The Medical Journal of Australia. ,vol. 159, pp. 766- 772 ,(1993) , 10.5694/J.1326-5377.1993.TB141344.X
G. H. Sato, J. Mendelsohn, J. Polikoff, J. D. Sato, A. D. Le, T. Kawamoto, Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Molecular biology & medicine. ,vol. 1, pp. 511- 529 ,(1983)
M D Pegram, R J Pietras, S B Howell, V R Chazin, B M Fendly, D J Slamon, Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene. ,vol. 9, pp. 1829- 1838 ,(1994)
Early Breast Cancer Trialist's Collaborative Group, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. The Lancet. ,(1992) , 10.1016/0140-6736(92)90997-H
Mark D. Pegram, Gottfried Konecny, Angela Lopez, Dennis J. Slamon, Trastuzumab and chemotherapeutics: drug interactions and synergies. Seminars in Oncology. ,vol. 27, pp. 21- 25 ,(2000)
A. Cho, Collective Effort Makes the Good Times Roll Science. ,vol. 297, pp. 33- 33 ,(2002) , 10.1126/SCIENCE.297.5578.33
Nick J. Dibb, Stephen M. Dilworth, Clifford D. Mol, Switching on kinases: oncogenic activation of BRAF and the PDGFR family. Nature Reviews Cancer. ,vol. 4, pp. 718- 727 ,(2004) , 10.1038/NRC1434
Olle Stål, Gizeh Pérez-Tenorio, Linda Åkerberg, Birgit Olsson, Bo Nordenskjöld, Lambert Skoog, Lars Erik Rutqvist, Akt kinases in breast cancer and the results of adjuvant therapy Breast Cancer Research. ,vol. 5, pp. 1- 8 ,(2003) , 10.1186/BCR569
G. E. J. Staal, A. E. Ottenhoff-Kalff, A. A. Michels, G. Rijksen, E. A. C. M. van Beurden, A. Hennipman, Characterization of Protein Tyrosine Kinases from Human Breast Cancer: Involvement of the c-src Oncogene Product Cancer Research. ,vol. 52, pp. 4773- 4778 ,(1992)
Hua Yu, Richard Jove, The STATs of cancer — new molecular targets come of age Nature Reviews Cancer. ,vol. 4, pp. 97- 105 ,(2004) , 10.1038/NRC1275